IBDEI0TI ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13276,2)
 ;;=^5005856
 ;;^UTILITY(U,$J,358.3,13277,0)
 ;;=H40.32X1^^51^632^8
 ;;^UTILITY(U,$J,358.3,13277,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13277,1,3,0)
 ;;=3^Traumatic GLC,OS,Mild Stage
 ;;^UTILITY(U,$J,358.3,13277,1,4,0)
 ;;=4^H40.32X1
 ;;^UTILITY(U,$J,358.3,13277,2)
 ;;=^5005857
 ;;^UTILITY(U,$J,358.3,13278,0)
 ;;=H40.32X2^^51^632^9
 ;;^UTILITY(U,$J,358.3,13278,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13278,1,3,0)
 ;;=3^Traumatic GLC,OS,Moderate Stage
 ;;^UTILITY(U,$J,358.3,13278,1,4,0)
 ;;=4^H40.32X2
 ;;^UTILITY(U,$J,358.3,13278,2)
 ;;=^5005858
 ;;^UTILITY(U,$J,358.3,13279,0)
 ;;=H40.32X3^^51^632^10
 ;;^UTILITY(U,$J,358.3,13279,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13279,1,3,0)
 ;;=3^Traumatic GLC,OS,Severe Stage
 ;;^UTILITY(U,$J,358.3,13279,1,4,0)
 ;;=4^H40.32X3
 ;;^UTILITY(U,$J,358.3,13279,2)
 ;;=^5133504
 ;;^UTILITY(U,$J,358.3,13280,0)
 ;;=H40.32X4^^51^632^11
 ;;^UTILITY(U,$J,358.3,13280,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13280,1,3,0)
 ;;=3^Traumatic GLC,OS,Indeterminate Stage
 ;;^UTILITY(U,$J,358.3,13280,1,4,0)
 ;;=4^H40.32X4
 ;;^UTILITY(U,$J,358.3,13280,2)
 ;;=^5005859
 ;;^UTILITY(U,$J,358.3,13281,0)
 ;;=H35.3230^^51^633^25
 ;;^UTILITY(U,$J,358.3,13281,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13281,1,3,0)
 ;;=3^Exud AMD,OU,Stage Unspec
 ;;^UTILITY(U,$J,358.3,13281,1,4,0)
 ;;=4^H35.3230
 ;;^UTILITY(U,$J,358.3,13281,2)
 ;;=^5138528
 ;;^UTILITY(U,$J,358.3,13282,0)
 ;;=H35.3231^^51^633^26
 ;;^UTILITY(U,$J,358.3,13282,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13282,1,3,0)
 ;;=3^Exud AMD,OU w/ Activ Chrdl Neovas
 ;;^UTILITY(U,$J,358.3,13282,1,4,0)
 ;;=4^H35.3231
 ;;^UTILITY(U,$J,358.3,13282,2)
 ;;=^5138529
 ;;^UTILITY(U,$J,358.3,13283,0)
 ;;=H35.3232^^51^633^27
 ;;^UTILITY(U,$J,358.3,13283,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13283,1,3,0)
 ;;=3^Exud AMD,OU w/ Inact Chrdl Neovas
 ;;^UTILITY(U,$J,358.3,13283,1,4,0)
 ;;=4^H35.3232
 ;;^UTILITY(U,$J,358.3,13283,2)
 ;;=^5138530
 ;;^UTILITY(U,$J,358.3,13284,0)
 ;;=H35.3233^^51^633^28
 ;;^UTILITY(U,$J,358.3,13284,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13284,1,3,0)
 ;;=3^Exud AMD,OU w/ Inactive Scar
 ;;^UTILITY(U,$J,358.3,13284,1,4,0)
 ;;=4^H35.3233
 ;;^UTILITY(U,$J,358.3,13284,2)
 ;;=^5138531
 ;;^UTILITY(U,$J,358.3,13285,0)
 ;;=H35.3220^^51^633^21
 ;;^UTILITY(U,$J,358.3,13285,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13285,1,3,0)
 ;;=3^Exud AMD,OS,Stage Unspec
 ;;^UTILITY(U,$J,358.3,13285,1,4,0)
 ;;=4^H35.3220
 ;;^UTILITY(U,$J,358.3,13285,2)
 ;;=^5138524
 ;;^UTILITY(U,$J,358.3,13286,0)
 ;;=H35.3221^^51^633^22
 ;;^UTILITY(U,$J,358.3,13286,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13286,1,3,0)
 ;;=3^Exud AMD,OS w/ Actv Chrdl Neovas
 ;;^UTILITY(U,$J,358.3,13286,1,4,0)
 ;;=4^H35.3221
 ;;^UTILITY(U,$J,358.3,13286,2)
 ;;=^5138525
 ;;^UTILITY(U,$J,358.3,13287,0)
 ;;=H35.3222^^51^633^23
 ;;^UTILITY(U,$J,358.3,13287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13287,1,3,0)
 ;;=3^Exud AMD,OS w/ Inact Chrdl Neovas
 ;;^UTILITY(U,$J,358.3,13287,1,4,0)
 ;;=4^H35.3222
 ;;^UTILITY(U,$J,358.3,13287,2)
 ;;=^5138526
 ;;^UTILITY(U,$J,358.3,13288,0)
 ;;=H35.3223^^51^633^24
 ;;^UTILITY(U,$J,358.3,13288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13288,1,3,0)
 ;;=3^Exud AMD,OS w/ Inactive Scar
 ;;^UTILITY(U,$J,358.3,13288,1,4,0)
 ;;=4^H35.3223
 ;;^UTILITY(U,$J,358.3,13288,2)
 ;;=^5138527
 ;;^UTILITY(U,$J,358.3,13289,0)
 ;;=H35.3210^^51^633^17
